文献速递重症综合管理与镇静镇痛儿科与产科急症

Phoenix脓毒症标准与Phoenix脓毒症评分在疑似感染PICU患者中的预测与预后性能:多中心前瞻性研究

Predictive and Prognostic Performance of the Phoenix Sepsis Criteria and Phoenix Sepsis Score in PICU Patients With Suspected Infection: A Multicenter Prospective Study.
PubMed 文献 · Crit Care Med · 2026-01-14
一句话结论在疑似感染的PICU患儿中,Phoenix脓毒症标准诊断脓毒症的敏感性和阳性预测值优于IPSCC标准,PELOD-2对死亡的预后判别力最高。

该多中心前瞻性队列研究纳入意大利8个PICU中687例疑似感染的18岁以下患儿,比较Phoenix脓毒症标准(PSC)与IPSCC标准的预测性能,以及Phoenix脓毒症评分(PSS)、Phoenix-8、PELOD-2等器官功能障碍评分对PICU死亡的预后性能。主要结局为PICU死亡。PSC在第1天和第2天的敏感性和阳性预测值均高于IPSCC标准;PELOD-2的精确率-召回率曲线下面积(AUPRC)最高(第1天0.45,第2天0.59)。所有预后评分从第1天到第2天性能均改善。这是首次在欧洲队列中验证PSC和PSS。

要点

  • 在687例疑似感染PICU患儿中,第1天PSC预测死亡的敏感性96.4%(95%CI 95.0-97.8%)、阳性预测值7.6%(95%CI 5.6-9.6%),高于IPSCC标准的敏感性82.1%(95%CI 79.3-85.0%)、阳性预测值6.2%(95%CI 4.4-8.0%)。
  • 第2天PSC敏感性100.0%(95%CI 100.0-100.0%)、阳性预测值10.0%(95%CI 7.6-12.5%),IPSCC标准敏感性75.0%(95%CI 71.5-78.5%)、阳性预测值9.0%(95%CI 6.7-11.3%)。
  • PELOD-2对PICU死亡的AUPRC最高:第1天0.45(95%CI 0.26-0.63),第2天0.59(95%CI 0.38-0.77)。
  • IPSCC严重脓毒症评分的预后性能低于所有其他器官功能障碍评分,包括PSS和Phoenix-8。
  • 所有预后评分的性能从第1天到第2天均改善。

适用人群与场景

  • 意大利PICU研究组网络(TIPNet)8个PICU中,2022年2月至2024年4月收治的18岁以下疑似感染患儿,共687例。

诊断标准与关键阈值

  • 脓毒症分别采用IPSCC标准和Phoenix脓毒症标准(PSC)评估;器官功能障碍评分包括IPSCC严重脓毒症、Phoenix脓毒症评分(PSS)、Phoenix-8、PELOD-2、儿科序贯器官衰竭评估(pSOFA)和儿科多器官功能障碍评分(P-MODS)。

研究设计与关键结果

  • 多中心前瞻性队列研究,纳入8个PICU中687例疑似感染患儿,无干预,主要结局为PICU死亡。
  • 第1天PSC预测死亡的敏感性96.4%(95%CI 95.0-97.8%)、阳性预测值7.6%(95%CI 5.6-9.6%);IPSCC标准敏感性82.1%(95%CI 79.3-85.0%)、阳性预测值6.2%(95%CI 4.4-8.0%)。
  • 第2天PSC敏感性100.0%(95%CI 100.0-100.0%)、阳性预测值10.0%(95%CI 7.6-12.5%);IPSCC标准敏感性75.0%(95%CI 71.5-78.5%)、阳性预测值9.0%(95%CI 6.7-11.3%)。
  • PELOD-2对PICU死亡的AUPRC最高:第1天0.45(95%CI 0.26-0.63),第2天0.59(95%CI 0.38-0.77)。
  • IPSCC严重脓毒症评分的预后性能低于所有其他器官功能障碍评分,包括PSS和Phoenix-8。
  • 所有预后评分的性能从第1天到第2天均改善。

证据类型、等级与局限

  • 证据类型:多中心前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,PSC和PSS在诊断和预后判断儿童脓毒症方面性能优于IPSCC标准,且在PICU入院第2天性能改善。
  • 作者指出,本研究首次在欧洲队列中验证了PSC和PSS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Evaluate the predictive and prognostic performance of the Phoenix Sepsis Criteria (PSC) and Phoenix Sepsis Score (PSS) compared with International Pediatric Sepsis Consensus Conference (IPSCC) criteria and other organ dysfunction scores in children admitted to the PICU with suspected infection.

DESIGN: Multicenter, prospective cohort study.

SETTING: Eight PICUs within the Italian Network of PICU Study Group (TIPNet).

PATIENTS: Patients younger than 18 years admitted with suspected infection (from February 2022 to April 2024).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Vital signs, organ dysfunction markers, and organ support requirements were collected during day 1 and day 2 of PICU admission. Sepsis was assessed using IPSCC criteria and PSC. IPSCC Severe Sepsis, PSS, Phoenix-8, Pediatric Logistic Organ Dysfunction-2 (PELOD-2), pediatric Sequential Organ Failure Assessment, and Pediatric Multiple Organ Dysfunction Score were calculated as organ dysfunction scores. Sepsis criteria predictive performance was assessed using sensitivity and positive predictive value (PPV). Organ dysfunction scores prognostic performance was assessed using the area under the precision-recall curve (AUPRC). Primary outcome was PICU mortality. Among 687 patients, PSC showed higher predictive performance than IPSCC sepsis criteria, with improved sensitivity and PPV for mortality on day 1 (PSC: sensitivity, 96.4%; 95% CI, 95.0-97.8%; PPV, 7.6%; 95% CI, 5.6-9.6% and IPSCC: sensitivity, 82.1%; 95% CI, 79.3-85.0%; PPV, 6.2%; 95% CI, 4.4-8.0%) and day 2 (PSC: sensitivity, 100.0%; 95% CI, 100.0-100.0%; PPV, 10.0%; 95% CI, 7.6-12.5% and IPSCC: sensitivity, 75.0%; 95% CI, 71.5-78.5%; PPV, 9.0%; 95% CI, 6.7-11.3%). PELOD-2 exhibited the highest AUPRC for mortality (day 1, 0.45; 95% CI, 0.26-0.63 and day 2, 0.59; 95% CI, 0.38-0.77). IPSCC Severe Sepsis score was outperformed by all other organ dysfunction scores, including PSS and Phoenix-8. All prognostic performances improved from day 1 to day 2.

CONCLUSIONS: PSC and PSS performed superior to IPSCC criteria in diagnosing and prognosticating pediatric sepsis, with improved performance at day 2 of PICU admission. This study first validated PSC and PSS in a European cohort.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Marchetto L, Daverio M, Comoretto R, et al. Predictive and Prognostic Performance of the Phoenix Sepsis Criteria and Phoenix Sepsis Score in PICU Patients With Suspected Infection: A Multicenter Prospective Study. Crit Care Med. 2026. PMID: 41532812. doi:10.1097/CCM.0000000000007034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。